Selection of LNA-containing DNA aptamers against recombinant human CD73

Ida C Elle, Kasper K Karlsen, Mikkel G Terp, Niels Larsen, Ronni Nielsen, Nicola Derbyshire, Susanne Mandrup, Henrik J Ditzel, Jesper Wengel

Research output: Contribution to journalJournal articleResearchpeer-review

195 Downloads (Pure)

Abstract

LNA-containing DNA aptamers against CD73 (human ecto-5'-nucleotidase), a protein frequently overexpressed in solid tumours, were isolated by SELEX. A pre-defined stem-loop library, containing LNA in the forward primer region, was enriched with CD73 binding sequences through six rounds of SELEX with recombinant his-tagged CD73 immobilised on anti-his plates. Enriched pools isolated from rounds one, three and six were subjected to next-generation sequencing and analysed for enrichment using custom bioinformatics software. The software identified aptamer sequences via the primers and then performed several steps including sequence unification, clustering and alignment to identify enriched sequences. Three enriched sequences were synthesised for further analysis, two of which showed sequence similarities. These sequences exhibited binding to the recombinant CD73 with KD values of 10 nM and 3.5 nM when tested by surface plasmon resonance. Truncated variants of these aptamers and variants where the LNA nucleotides were substituted for the DNA equivalent also exhibited affinity for the recombinant CD73 in the low nanomolar range. In enzyme inhibition assays with recombinant CD73 the aptamer sequences were able to decrease the activity of the protein. However, the aptamers exhibited no binding to cellular CD73 by flow cytometry analysis likely since the epitope recognised by the aptamer was not available for binding on the cellular protein.

Original languageEnglish
JournalMolecular BioSystems
Volume11
Issue number5
Pages (from-to)1260-1270
ISSN1742-206X
DOIs
Publication statusPublished - 21. Apr 2015

Fingerprint

Nucleotide Aptamers
Surface Plasmon Resonance
Computational Biology
Libraries
Cluster Analysis
Flow Cytometry
Proteins
DNA
Neoplasms

Cite this

@article{4d4c16c7154645a1bab9cd4f98781b7a,
title = "Selection of LNA-containing DNA aptamers against recombinant human CD73",
abstract = "LNA-containing DNA aptamers against CD73 (human ecto-5'-nucleotidase), a protein frequently overexpressed in solid tumours, were isolated by SELEX. A pre-defined stem-loop library, containing LNA in the forward primer region, was enriched with CD73 binding sequences through six rounds of SELEX with recombinant his-tagged CD73 immobilised on anti-his plates. Enriched pools isolated from rounds one, three and six were subjected to next-generation sequencing and analysed for enrichment using custom bioinformatics software. The software identified aptamer sequences via the primers and then performed several steps including sequence unification, clustering and alignment to identify enriched sequences. Three enriched sequences were synthesised for further analysis, two of which showed sequence similarities. These sequences exhibited binding to the recombinant CD73 with KD values of 10 nM and 3.5 nM when tested by surface plasmon resonance. Truncated variants of these aptamers and variants where the LNA nucleotides were substituted for the DNA equivalent also exhibited affinity for the recombinant CD73 in the low nanomolar range. In enzyme inhibition assays with recombinant CD73 the aptamer sequences were able to decrease the activity of the protein. However, the aptamers exhibited no binding to cellular CD73 by flow cytometry analysis likely since the epitope recognised by the aptamer was not available for binding on the cellular protein.",
author = "Elle, {Ida C} and Karlsen, {Kasper K} and Terp, {Mikkel G} and Niels Larsen and Ronni Nielsen and Nicola Derbyshire and Susanne Mandrup and Ditzel, {Henrik J} and Jesper Wengel",
year = "2015",
month = "4",
day = "21",
doi = "10.1039/c5mb00045a",
language = "English",
volume = "11",
pages = "1260--1270",
journal = "Molecular BioSystems",
issn = "1742-206X",
publisher = "Royal Society of Chemistry",
number = "5",

}

Selection of LNA-containing DNA aptamers against recombinant human CD73. / Elle, Ida C; Karlsen, Kasper K; Terp, Mikkel G; Larsen, Niels; Nielsen, Ronni; Derbyshire, Nicola; Mandrup, Susanne; Ditzel, Henrik J; Wengel, Jesper.

In: Molecular BioSystems, Vol. 11, No. 5, 21.04.2015, p. 1260-1270.

Research output: Contribution to journalJournal articleResearchpeer-review

TY - JOUR

T1 - Selection of LNA-containing DNA aptamers against recombinant human CD73

AU - Elle, Ida C

AU - Karlsen, Kasper K

AU - Terp, Mikkel G

AU - Larsen, Niels

AU - Nielsen, Ronni

AU - Derbyshire, Nicola

AU - Mandrup, Susanne

AU - Ditzel, Henrik J

AU - Wengel, Jesper

PY - 2015/4/21

Y1 - 2015/4/21

N2 - LNA-containing DNA aptamers against CD73 (human ecto-5'-nucleotidase), a protein frequently overexpressed in solid tumours, were isolated by SELEX. A pre-defined stem-loop library, containing LNA in the forward primer region, was enriched with CD73 binding sequences through six rounds of SELEX with recombinant his-tagged CD73 immobilised on anti-his plates. Enriched pools isolated from rounds one, three and six were subjected to next-generation sequencing and analysed for enrichment using custom bioinformatics software. The software identified aptamer sequences via the primers and then performed several steps including sequence unification, clustering and alignment to identify enriched sequences. Three enriched sequences were synthesised for further analysis, two of which showed sequence similarities. These sequences exhibited binding to the recombinant CD73 with KD values of 10 nM and 3.5 nM when tested by surface plasmon resonance. Truncated variants of these aptamers and variants where the LNA nucleotides were substituted for the DNA equivalent also exhibited affinity for the recombinant CD73 in the low nanomolar range. In enzyme inhibition assays with recombinant CD73 the aptamer sequences were able to decrease the activity of the protein. However, the aptamers exhibited no binding to cellular CD73 by flow cytometry analysis likely since the epitope recognised by the aptamer was not available for binding on the cellular protein.

AB - LNA-containing DNA aptamers against CD73 (human ecto-5'-nucleotidase), a protein frequently overexpressed in solid tumours, were isolated by SELEX. A pre-defined stem-loop library, containing LNA in the forward primer region, was enriched with CD73 binding sequences through six rounds of SELEX with recombinant his-tagged CD73 immobilised on anti-his plates. Enriched pools isolated from rounds one, three and six were subjected to next-generation sequencing and analysed for enrichment using custom bioinformatics software. The software identified aptamer sequences via the primers and then performed several steps including sequence unification, clustering and alignment to identify enriched sequences. Three enriched sequences were synthesised for further analysis, two of which showed sequence similarities. These sequences exhibited binding to the recombinant CD73 with KD values of 10 nM and 3.5 nM when tested by surface plasmon resonance. Truncated variants of these aptamers and variants where the LNA nucleotides were substituted for the DNA equivalent also exhibited affinity for the recombinant CD73 in the low nanomolar range. In enzyme inhibition assays with recombinant CD73 the aptamer sequences were able to decrease the activity of the protein. However, the aptamers exhibited no binding to cellular CD73 by flow cytometry analysis likely since the epitope recognised by the aptamer was not available for binding on the cellular protein.

U2 - 10.1039/c5mb00045a

DO - 10.1039/c5mb00045a

M3 - Journal article

C2 - 25720604

VL - 11

SP - 1260

EP - 1270

JO - Molecular BioSystems

JF - Molecular BioSystems

SN - 1742-206X

IS - 5

ER -